A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis
A. Nasir; R. Bissonnette; C. Maari; J. DuBois; T. Pene Dumitrescu; J. Haddad; Y. Yamaguchi; M. Dalessandro
Author Information: Wake Research Institute
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.